General Information
Get notified when DyNAbind GmbH moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track DyNAbind GmbH
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Germany Market
Biopharma
About DyNAbind GmbH
Taxonomy: Drug Discovery, DNA-Encoded Libraries, Small Molecule Discovery, Fragment-Based Discovery, Medicinal Chemistry, Pharmaceutical Research, Biotechnology Innovation, High-Throughput Screening, Protein Targets, Innovative Technology, Biotech Partnership, Academic Collaborations
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 3 |
|
08 May 2019 |
DyNAbind GmbH Alternatives & Competitors
AlphaMa is a pioneering drug R&D company based on AI and DEL drug discovery innovation platform.
Targeting the undruggable with synthetic biology-based drug discovery platforms
Designing novel proteins, enzymes, and antibodies is limited by the problem of generating and screen...
FAQ About DyNAbind GmbH
Don't just browse. Track.
Signal Tracker monitors DyNAbind GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.